Vigabatrin 500 mg Oral Tablet
RxNorm 199521
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 199521 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: vigabatrin 500 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Vigabatrin 500 mg Oral Tablet
(Atom ID: 12324475)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely vigabatrin 500 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10318301)
PSNPrescribable
Prescribable Name (PSN):
Vigabatrin 500 mg Oral Tablet
(Atom ID: 6365940)
PTPrescribable
Designated preferred name (PT):
Vigabatrin 500 mg oral tablet
(Atom ID: 9265360)
Patient Education
Vigabatrin
Vigabatrin tablets are used in combination with other medications to control certain types of seizures in adults and children 10 years of age or older whose seizures were not controlled by several other medications. Vigabatrin powder is used to control infantile spasms (a type of seizure that babies and children can have) in babies 1 month to 2 years of age. Vigabatrin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.